Raleigh, NC, May 24, 2014 --(PR.com
)-- Raleigh-based Wake Research (Wake Research Associates, L.L.C.) announces an affiliation with Dr. Jane Rohlf and Premier Research, of Trenton, New Jersey.
“Dr. Rohlf brings wealth of research expertise and her site fit well into our strategic plan to offer Biopharmaceutical Industry a broad geographic area for the conduct of clinical research, coordinated by Wake Research,” said Wake Research President & CEO, Dr. Ella Grach. “We look forward to working with them on many successful clinical research trials.”
This relationship gives Wake Research and its partners operations in 11 North American communities (Trenton, New Jersey, Raleigh, Holly Springs, Benson and Durham in North Carolina, Atlanta, Johns Creek and Sandy Springs, Georgia, Sugar Land, Texas, Dothan Alabama and Jackson, Mississippi) with a subject database of nearly 515,000 individuals.
The partnership means more physician investigators to collaborate with the pharmaceutical, biotech and device industry, in more communities with larger subject databases.
Dr. Rohlf has practiced medicine since 1975, and founded Premier Research in 1997. Her prior experience includes more than a decade working in leadership positions at Pharmaceutical companies: Bristol-Myers Squibb and Hoechst-Roussel Pharmaceuticals.
About Wake Research
Wake Research is an Organization of Integrated Investigational Sites, working closely with and meeting the needs of the biopharmaceutical, biotechnology, medical device and pharmaceutical industries. Wake Research is fully equipped to meet the needs of sponsors and CROs in the conduct of Phase I-IV clinical trials in a large variety of indications. With nearly thirty years of clinical research experience, more than 2,500 successful clinical trials and a combined subject database of 515,000, Wake Research has consistently exceed sponsor expectation for integrity, subject enrollment, human protection and expeditious delivery of accurate evaluable data.
Wake Research is a unique and innovative resource for Phase I through Phase IV clinical trials with 45+ well diverse principal investigators specializing in gastroenterology, musculoskeletal disorders, metabolic disorders, dermatology, vaccines including bio-defense research, CNS/sleep disorders. Our company is known for effectively combining strategic volunteer recruitment and retention with high quality clinical trial conduct. Our approach is uncompromising - each study conducted at our sites is carefully planned and executed according to regulations with superior quality.
About Premier Research
Premier Research was founded in 1997 by Dr. Jane Rohlf, who has nearly three decades of industry experience. It is a premier clinical research site, conducting more than 150 research trials across disciplines to meet the pharmaceutical industry’s needs.
Joining her in clinical research are Mark Seelagy, MD and Salman Muddassir, MD. Dr. Seelagy has more nearly two decades of experience. Dr. Muddassir brings a decade of experience to the group.